BG
XENT

Bellevue Group’s Intersect ENT, Inc XENT Stock Holding History

Bellevue Group’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-617,968
Closed -$10.6M – 225
2021
Q2 		$10.6M Hold
617,968
– – 0.1% 123
2021
Q1 		$12.9M Sell
617,968
-1,513
-0.2% -$34.9K 0.14% 115
2020
Q4 		$14.2M Buy
619,481
+146,099
+31% +$2.78M 0.16% 108
2020
Q3 		$7.72M Sell
473,382
-89,708
-16% -$1.62M 0.11% 118
2020
Q2 		$7.62M Buy
563,090
+18,068
+3% +$210K 0.11% 115
2020
Q1 		$6.46M Sell
545,022
-25,880
-5% -$574K 0.13% 106
2019
Q4 		$14.2M Buy
570,902
+112,314
+24% +$2.28M 0.23% 75
2019
Q3 		$7.8M Buy
458,588
+7,870
+2% +$143K 0.15% 95
2019
Q2 		$10.3M Buy
450,718
+122,331
+37% +$3.3M 0.18% 85
2019
Q1 		$10.6M Buy
328,387
+90,943
+38% +$2.81M 0.58% 51
2018
Q4 		$6.69M Buy
237,444
+3,217
+1% +$94.2K 0.44% 54
2018
Q3 		$6.73M Buy
234,227
+146,199
+166% +$4.39M 0.43% 63
2018
Q2 		$3.3M Buy
88,028
+49,598
+129% +$1.95M 0.28% 69
2018
Q1 		$1.51M Hold
38,430
– – 0.15% 95
2017
Q4 		$1.25M Sell
38,430
-2,570
-6% -$77.1K 0.13% 101
2017
Q3 		$1.28M Sell
41,000
-59,000
-59% -$1.75M 0.13% 104
2017
Q2 		$2.79M Hold
100,000
– – 0.33% 68
2017
Q1 		$1.72M Sell
100,000
-30,000
-23% -$420K 0.23% 84
2016
Q4 		$1.57M Sell
130,000
-75,325
-37% -$975K 0.32% 74
2016
Q3 		$3.25M Hold
205,325
– – 0.59% 52
2016
Q2 		$2.65M Sell
205,325
-3,921
-2% -$61.4K 0.5% 63
2016
Q1 		$3.98M Buy
+209,246
New +$3.79M 0.72% 48

Other funds holding XENT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Group's XENT Position: Q3 2021 in Review

Bellevue Group sold out of Intersect ENT, Inc (XENT) in Q3 2021, closing a stake of 617,968 shares — an estimated $10.6M sold.

Bellevue Group first reported a position in XENT in Q1 2016 and held it in 22 quarters. The position peaked at $14.2M in Q4 2019. 123 funds tracked by Wall St. Rank hold XENT as of Q3 2021.

  • Bellevue Group reported no remaining Intersect ENT, Inc position as of Q3 2021 after selling out during the quarter.
  • Bellevue Group sold 617,968 Intersect ENT, Inc shares in Q3 2021, an estimated $10.6M.
  • Bellevue Group first reported a position in Intersect ENT, Inc in Q1 2016 and held it in 22 quarters.
  • Bellevue Group's Intersect ENT, Inc position peaked at $14.2M in Q4 2019.
  • 123 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2021.

Based on Bellevue Group's 13F filing for Q3 2021, filed 12 Nov 2021.